AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 132 filers reported holding AMPIO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | -100.0% | 680 | -98.3% | 0.00% | – |
| Q2 2022 | $7,000 | +16.7% | 41,054 | +197.1% | 0.00% | – |
| Q1 2022 | $6,000 | -79.3% | 13,820 | -72.8% | 0.00% | – |
| Q4 2021 | $29,000 | -27.5% | 50,893 | +112.0% | 0.00% | – |
| Q3 2021 | $40,000 | +150.0% | 24,009 | +151.3% | 0.00% | – |
| Q2 2021 | $16,000 | +1500.0% | 9,553 | +1810.6% | 0.00% | – |
| Q1 2021 | $1,000 | -90.0% | 500 | -92.3% | 0.00% | – |
| Q4 2020 | $10,000 | -9.1% | 6,500 | -43.5% | 0.00% | – |
| Q3 2020 | $11,000 | +57.1% | 11,500 | 0.0% | 0.00% | – |
| Q2 2020 | $7,000 | +40.0% | 11,500 | 0.0% | 0.00% | – |
| Q1 2020 | $5,000 | -73.7% | 11,500 | -65.1% | 0.00% | – |
| Q4 2019 | $19,000 | +11.8% | 32,940 | 0.0% | 0.00% | – |
| Q3 2019 | $17,000 | -22.7% | 32,940 | -42.2% | 0.00% | – |
| Q2 2019 | $22,000 | -35.3% | 56,978 | -4.9% | 0.00% | – |
| Q1 2019 | $34,000 | +21.4% | 59,887 | -14.1% | 0.00% | – |
| Q4 2018 | $28,000 | -51.7% | 69,681 | -39.2% | 0.00% | – |
| Q3 2018 | $58,000 | -59.2% | 114,567 | +77.1% | 0.00% | – |
| Q2 2018 | $142,000 | -38.0% | 64,692 | -4.0% | 0.00% | – |
| Q1 2018 | $229,000 | +7533.3% | 67,400 | +1759.3% | 0.00% | – |
| Q1 2017 | $3,000 | -93.6% | 3,625 | -93.0% | 0.00% | – |
| Q4 2016 | $47,000 | +840.0% | 51,561 | +631.6% | 0.00% | – |
| Q3 2016 | $5,000 | -54.5% | 7,048 | -16.4% | 0.00% | – |
| Q2 2016 | $11,000 | +22.2% | 8,426 | +109.8% | 0.00% | – |
| Q1 2016 | $9,000 | -40.0% | 4,017 | -10.3% | 0.00% | – |
| Q4 2015 | $15,000 | -11.8% | 4,478 | -24.8% | 0.00% | – |
| Q3 2015 | $17,000 | +54.5% | 5,954 | +29.0% | 0.00% | – |
| Q2 2015 | $11,000 | -88.5% | 4,614 | -63.6% | 0.00% | – |
| Q1 2015 | $96,000 | +220.0% | 12,693 | +43.8% | 0.00% | – |
| Q4 2014 | $30,000 | +150.0% | 8,827 | +167.3% | 0.00% | – |
| Q3 2014 | $12,000 | -53.8% | 3,302 | +4.4% | 0.00% | – |
| Q2 2014 | $26,000 | -48.0% | 3,162 | -60.2% | 0.00% | – |
| Q1 2014 | $50,000 | -58.0% | 7,945 | -52.5% | 0.00% | – |
| Q4 2013 | $119,000 | +11800.0% | 16,721 | +15977.9% | 0.00% | – |
| Q3 2013 | $1,000 | – | 104 | +188.9% | 0.00% | – |
| Q2 2013 | $0 | – | 36 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVA Family Office, LLC | 1,173,200 | $1,865,000 | 1.14% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $1,387,000 | 0.82% |
| Cypress Capital Management LLC (WY) | 214,575 | $341,000 | 0.30% |
| Western Wealth Management, LLC | 982,350 | $1,562,000 | 0.23% |
| SRS Capital Advisors, Inc. | 615,659 | $979,000 | 0.14% |
| Willis Investment Counsel | 1,213,053 | $1,929,000 | 0.13% |
| Harvest Investment Services, LLC | 124,423 | $197,000 | 0.10% |
| Transform Wealth, LLC | 205,481 | $327,000 | 0.07% |
| COURIER CAPITAL LLC | 379,973 | $604,000 | 0.07% |
| BRIGHTON JONES LLC | 398,912 | $634,000 | 0.04% |